Epigenetic-Mediated Reprogramming of Pancreatic Endocrine Cells

Prabhu Mathiyalagan, Samuel T. Keating, Keith Al-Hasani, Assam El-Osta

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Significance: Type 1 diabetes (T1D) results from cell-mediated autoimmune destruction of insulin-secreting pancreatic beta cells (β-cells). In the context of T1D, the scarcity of organ donors has driven research to alternate sources of functionally competent, insulin-secreting β-cells as substitute for donor islets to meet the clinical need for transplantation therapy. Recent Advances: Experimental evidence of an inherent plasticity of pancreatic cells has fuelled interest in in vivo regeneration of β-cells. Transcriptional modulation and direct reprogramming of noninsulin secreting pancreatic α-cells to functionally mimic insulin-secreting β-cells is one of the promising avenues to the treatment of diabetes. Recent studies now show that adult progenitor and glucagon+ α-cells can be converted into β-like cells in vivo, as a result of specific activation of the Pax4 gene in α-cells and curing diabetes in preclinical models. Critical Issues: The challenge now is to understand the precise developmental transitions mediated by endocrine transcription factors and co-regulatory determinants responsible for pancreatic function and repair. Future Directions: Epigenetic-mediated regulation of transcription factor binding in pancreatic α-cells by specific drugs to direct reprogramming into functional insulin producing cells could be of potential innovative therapy for the treatment of T1D.

Original languageEnglish
Pages (from-to)1483-1495
Number of pages13
JournalAntioxidants and Redox Signaling
Volume22
Issue number16
DOIs
Publication statusPublished - 1 Jun 2015

Cite this

Mathiyalagan, Prabhu ; Keating, Samuel T. ; Al-Hasani, Keith ; El-Osta, Assam. / Epigenetic-Mediated Reprogramming of Pancreatic Endocrine Cells. In: Antioxidants and Redox Signaling. 2015 ; Vol. 22, No. 16. pp. 1483-1495.
@article{81e6ebb84629465ab9209f99892a57ec,
title = "Epigenetic-Mediated Reprogramming of Pancreatic Endocrine Cells",
abstract = "Significance: Type 1 diabetes (T1D) results from cell-mediated autoimmune destruction of insulin-secreting pancreatic beta cells (β-cells). In the context of T1D, the scarcity of organ donors has driven research to alternate sources of functionally competent, insulin-secreting β-cells as substitute for donor islets to meet the clinical need for transplantation therapy. Recent Advances: Experimental evidence of an inherent plasticity of pancreatic cells has fuelled interest in in vivo regeneration of β-cells. Transcriptional modulation and direct reprogramming of noninsulin secreting pancreatic α-cells to functionally mimic insulin-secreting β-cells is one of the promising avenues to the treatment of diabetes. Recent studies now show that adult progenitor and glucagon+ α-cells can be converted into β-like cells in vivo, as a result of specific activation of the Pax4 gene in α-cells and curing diabetes in preclinical models. Critical Issues: The challenge now is to understand the precise developmental transitions mediated by endocrine transcription factors and co-regulatory determinants responsible for pancreatic function and repair. Future Directions: Epigenetic-mediated regulation of transcription factor binding in pancreatic α-cells by specific drugs to direct reprogramming into functional insulin producing cells could be of potential innovative therapy for the treatment of T1D.",
author = "Prabhu Mathiyalagan and Keating, {Samuel T.} and Keith Al-Hasani and Assam El-Osta",
year = "2015",
month = "6",
day = "1",
doi = "10.1089/ars.2014.6103",
language = "English",
volume = "22",
pages = "1483--1495",
journal = "Antioxidants and Redox Signaling",
issn = "1523-0864",
publisher = "Mary Ann Liebert Inc",
number = "16",

}

Epigenetic-Mediated Reprogramming of Pancreatic Endocrine Cells. / Mathiyalagan, Prabhu; Keating, Samuel T.; Al-Hasani, Keith; El-Osta, Assam.

In: Antioxidants and Redox Signaling, Vol. 22, No. 16, 01.06.2015, p. 1483-1495.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Epigenetic-Mediated Reprogramming of Pancreatic Endocrine Cells

AU - Mathiyalagan, Prabhu

AU - Keating, Samuel T.

AU - Al-Hasani, Keith

AU - El-Osta, Assam

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Significance: Type 1 diabetes (T1D) results from cell-mediated autoimmune destruction of insulin-secreting pancreatic beta cells (β-cells). In the context of T1D, the scarcity of organ donors has driven research to alternate sources of functionally competent, insulin-secreting β-cells as substitute for donor islets to meet the clinical need for transplantation therapy. Recent Advances: Experimental evidence of an inherent plasticity of pancreatic cells has fuelled interest in in vivo regeneration of β-cells. Transcriptional modulation and direct reprogramming of noninsulin secreting pancreatic α-cells to functionally mimic insulin-secreting β-cells is one of the promising avenues to the treatment of diabetes. Recent studies now show that adult progenitor and glucagon+ α-cells can be converted into β-like cells in vivo, as a result of specific activation of the Pax4 gene in α-cells and curing diabetes in preclinical models. Critical Issues: The challenge now is to understand the precise developmental transitions mediated by endocrine transcription factors and co-regulatory determinants responsible for pancreatic function and repair. Future Directions: Epigenetic-mediated regulation of transcription factor binding in pancreatic α-cells by specific drugs to direct reprogramming into functional insulin producing cells could be of potential innovative therapy for the treatment of T1D.

AB - Significance: Type 1 diabetes (T1D) results from cell-mediated autoimmune destruction of insulin-secreting pancreatic beta cells (β-cells). In the context of T1D, the scarcity of organ donors has driven research to alternate sources of functionally competent, insulin-secreting β-cells as substitute for donor islets to meet the clinical need for transplantation therapy. Recent Advances: Experimental evidence of an inherent plasticity of pancreatic cells has fuelled interest in in vivo regeneration of β-cells. Transcriptional modulation and direct reprogramming of noninsulin secreting pancreatic α-cells to functionally mimic insulin-secreting β-cells is one of the promising avenues to the treatment of diabetes. Recent studies now show that adult progenitor and glucagon+ α-cells can be converted into β-like cells in vivo, as a result of specific activation of the Pax4 gene in α-cells and curing diabetes in preclinical models. Critical Issues: The challenge now is to understand the precise developmental transitions mediated by endocrine transcription factors and co-regulatory determinants responsible for pancreatic function and repair. Future Directions: Epigenetic-mediated regulation of transcription factor binding in pancreatic α-cells by specific drugs to direct reprogramming into functional insulin producing cells could be of potential innovative therapy for the treatment of T1D.

UR - http://www.scopus.com/inward/record.url?scp=84929346593&partnerID=8YFLogxK

U2 - 10.1089/ars.2014.6103

DO - 10.1089/ars.2014.6103

M3 - Review Article

VL - 22

SP - 1483

EP - 1495

JO - Antioxidants and Redox Signaling

JF - Antioxidants and Redox Signaling

SN - 1523-0864

IS - 16

ER -